Influence of fractionation and fluence rate in photodynamic therapy with photofrin or mTHPC

Radiation Research

Volumn 145, Issue 5, 1996, Pages 602-609

  Van Geel, I P J ^a   Oppelaar, H ^a   Marijnissen, J P A ^b   Steward, F A ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PHOTOFRIN; PHOTOSENSITIZING AGENT; TETRAHYDROXYPHENYLCHLORIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CANCER RECURRENCE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; FEMALE; ILLUMINATION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LIGHT EXPOSURE; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PHOTOSENSITIZATION; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION;

ANIMALS; DIHEMATOPORPHYRIN ETHER; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; LIGHT; MESOPORPHYRINS; MICE; MICE, INBRED C3H; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; SARCOMA, EXPERIMENTAL;

ANIMALIA;

EID: 0029912965     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.2307/3579279     Document Type: Article

References (21)

1. T. H. Foster, R. S. Murant, R. G. Bryant, R. S. Knox, S. L. Gibson and R. Hilf, Oxygen consumption and diffusion effects in photodynamic therapy. Radiat. Res. 126, 296-303 (1991).
2. B. W. Henderson, S. M. Waldow, T. S. Mang, W. R. Potter, P. B. Malone and T. J. Dougherty, Tumour destruction and kinetics of tumor cell death in two experimental mouse tumors following photodynamic therapy. Cancer Res. 45, 572-576 (1985).
3. W. M. Star, J. P. A. Marijnissen, A. E. Berg-Blok, J. A. C. Versteeg, K. A. P. Franken and H. S. Reinhold, Destruction of rat mammary tumour and normal tissue microcirculation by hematoporphyrin derivative photoirradiation observed in vivo in sandwich observation chambers. Cancer Res. 46, 2532-2540 (1986).
4. I. P. J. van Geel, H. Oppelaar, Y. G. Oussoren and F. A. Stewart, Changes in perfusion of mouse tumours after photodynamic therapy. Int. J. Cancer 56, 224-228 (1994).
5. G. Graschew, M. Shopova, G. Anastassova and A. Chakarova, Light dose fractionation versus single dose irradiation in photodynamic therapy of tumours. Lasers Med. Sci. 3, 173-177 (1988).
6. S. L. Gibson, K. R. Vandermeid, R. S. Murant, R. F. Raubertas and R. Hilf, Effects of various photoradiation regimens on the antitumour efficacy of photodynamic therapy for R3230AC mammary carcinomas. Cancer Res. 50, 7234-7241 (1990).
7. H. Anholt and J. Moan, Fractionated treatment of CaD2 tumors in mice sensitized with aluminium phthalocyantne tetrasulfonate. Cancer Lett. 61, 263-267 (1991).
8. J. F. Evensen and J. Moan, Photodynamic therapy of C3H tumours in mice: effect of drug/light dose fractionation and misonidazole. Lasers Med. Sci. 3, 1-6 (1988).
9. D. A. Bellnier and C. W. Lin, Photosensitization and split-dose recovery in cultured human urinary bladder carcinoma cells containing nonexchangeable hematoporphyrin derivative. Cancer Res. 45, 2507-2511 (1985).
10. S. L. Gibson, T. H. Foster, R. H. Feins, R. F. Raubertas, M. A. Fallon and R. Hilf, Effects of photodynamic therapy on xenografts of human mesothelioma and rat mammary carcinoma in nude mice. Br. J. Cancer 69, 473-481 (1994).
11. J. C. M. Bremner, G. E. Adams, J. K. Pearson, J. H. Sansom, I. J. Stratford, J. Bedwell, S. G. Bown, A. J. MacRobert and D. Philips, Increasing the effect of photodynamic therapy of the RIF-1 murine sarcoma, using the bioreductive drugs RSU1069 and RB6145. Br. J. Cancer 66, 1070-1076 (1992).
12. P. R Twentyman, J. M. Brown, J. W. Gray, A. J. Franko, M. A. Scoles and R. F. Kallman, A new mouse tumor model system (RIF-1) for comparison of end-point studies. J. Natl. Cancer Inst. 64, 594-604 (1980).
13. I. P. J. van Geel, H. Oppelaar, Y. G. Oussoren and F. A. Stewart, Photosensitizing efficacy of mTHPC-PDT compared to Photofrin-PDT in the RIF1 mouse tumour and normal skin. Int. J. Cancer 60, 388-394 (1995).
14. I. P. J. van Geel, H. Oppelaar, Y. G. Oussoren, J. J. Schuitmaker and F. A. Stewart, Mechanisms for optimizing PDT: second generation photosensitizers in combination with mitomycin C. Br. J. Cancer 72, 344-350 (1995).
15. P. Baas, C. Michielsen, H. Oppelaar, N. Zandwijk and F. A. Stewart, Enhancement of interstitial photodynamic therapy by Mitomycin C and EO9 in a mouse tumor model. Int. J. Cancer 56, 880-885 (1994).
16. C. P. Lowdell, D. V. Ash, I. Driver and S. B. Brown, Interstitial photodynamic therapy. Clinical experience with diffusing fibers in the treatment of cutaneous and subcutaneous tumours. Br. J. Cancer 67, 1398-1403 (1993).
17. T. S. Mang, T. J. Dougherty, W. R. Potter, D. G. Boyle, S. Somer and J. Moan, Photobleaching of porphyrins used in photodynamic therapy and implications for therapy. Photochem. Photobiol. 45, 501-506 (1987).
18. M. M. Elkind and H. Sutton, Radiation response of mammalian cells grown in culture. I. Repair of X-ray damage in surviving Chinese hamster cells. Radiat. Res. 13, 556-593 (1990).
19. R. Bonnet, R. D. White, U. Winfield and M. C. Berenbaum, Hydroporphyrins of the meso-tetra(hydroxyphenyl)porphyrin series as tumour photosensitizers. Biochem. J. 261, 277-280 (1989).
20. T. H. Foster, S. L. Gibson, L. Gao and R. Hilf, Analysis of photochemical consumption effects in photodynamic therapy. Proc. Biomed. Optics 1645 (1992).
21. I. P. J. van Geel, H. Oppelaar, P. F. J. W. Rijken, H. J. J. A. Bernsen, N. E. M. Hagemeier, A. J. van der Kogel, R. J. Hodgkiss and F. A. Stewart, Vascular perfusion and hvpoxic areas in RIF1 tumours after photodynamic therapy. Br. J. Cancer 73, 288-293 (1996).